Common Stock, par value $0.01
- Symbol
- ASPI
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 7.01, 9.01 · 8-K
ASP Isotopes Inc.
ASPINASDAQEQUITYCurrent
Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On January 29, 2026, ASP Isotopes Inc. (the “Company”) issued a press release providing a production update on the Helium Project of Renergen Limited, which is attached hereto as Exhibit 99.1 and is incorporated by reference herein (the “Press Release”).…
Press release in this filing
ASP Isotopes Inc. Provides Production Update on the Renergen Helium Project →Company context
ASP Isotopes Inc. is an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, including nuclear medicine, electronics and nuclear energy. The Company's proprietary Aerodynamic Separation Process ("ASP technology") and Quantum Enrichment ("QE technology") are designed to enable the production of isotopes for a range of industrial and advanced technology applications. The Company operates isotope enrichment facilities in Pretoria, South Africa, focused on low atomic mass elements, or light isotopes, and a gas production facility in Free State Province, South Africa, focused on liquid natural gas and liquid helium. For more information, please visit www.aspisotopes.com.
Current securities
Registered securities in this filing
ASP Isotopes Inc. · 8-K · Filed 2026-01-29
Disclosure sections
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.
On January 29, 2026, ASP Isotopes Inc. (the “Company”) issued a press release providing a production update on the Helium Project of Renergen Limited, which is attached hereto as Exhibit 99.1 and is incorporated by reference herein (the “Press Release”).
The information in this Item 7.01 and in the Press Release shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, and shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission, whether made by the Company before or after the date hereof, regardless of any general incorporation language in such filing.
The Press Release includes “safe harbor” language pursuant to the Private Securities Litigation Reform Act of 1995, as amended, indicating that certain statements contained therein are “forward-looking” rather than historical.
Filed exhibits (1)
EXHIBIT 99.1 ASP Isotopes Inc. Provides Production Update on the Renergen Helium Project This Production Update reports operational progress since April 2025, following bridge loan funding provided by ASP Isotopes Inc. (“ASPI”) (prior to the completion of ASPI’s acquisition of Renergen), and highlights measurable improvements in drilling execution, gas production, subsurface confidence, and commercial readiness since ASPI involvement. Key highlights include: Investment has augmented existing operational capacity. Management estimates the plant is now processing approximately 60% more gas as a result of improvements and new production wells tied to the plant. Significant improvement in subsurface capability following the engagement of Kinley Exploration: for the first time on the project, a globally recognised independent exploration, drilling and reservoir modelling specialist has been embedded post-restart, bringing industry-standard geological modelling, target allocation, well design and drilling expertise. Direct impact from Kinley Exploration now evident in drilling outcomes: wells are being drilled against modelled and delineated gas targets, resulting in higher…
Open exhibit ↗